J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India’s leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.
Financial Results:
J B Chemicals & Pharmaceuticals Ltd reported Revenues for Q2FY25 of ₹1,001.00 Crores up from ₹882.00 Crore year on year, a rise of 13.49%.
Total Expenses for Q2FY25 of ₹774.00 Crores up from ₹680.00 Crores year on year, a rise of 13.82%.
Consolidated Net Profit of ₹175.00 Crores up 15.89% from ₹151.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.24, up 15.64% from ₹9.72 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.